ProVerum
Manufacturing · Ireland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Astor Hall 4-8 Eden Quay Fl 2, Dublin, L...Phone Number
+353 15241340Website
www.proverummedical.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About ProVerum
ProVerum Ltd. is an innovative Dublin based company focused on the development of novel minimally invasive technologies to treat BPH. The company's first product offering, the ProVee® System for BPH is an investigational device, limited by federal law to investigational use and not available for sale within the United States.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ProVerum your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when ProVerum launches new products
Check out if ProVerum is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at ProVerum
Earning: See what the market has to say on ProVerum recently announced quarterly report
Click to see if ProVerum had a recent Job posting/layoffs
Funding: Get notified immidiatlly once ProVerum has new funding data
Check if ProVerum has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
ProVerum, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at ProVerum
Find more new buyers
Company Profile Activity
Activity Insights
ProVerum is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ProVerum is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ProVerum.
ProVerum financials insights
Gather financial insights about ProVerum, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series A
$34.1M
2025
Series B
$80M
ProVerum Tech Stack
A closer look at the technologies used by ProVerum
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
, according to a high-level source in advertising & promotion, is planning to begin initiatives related to video advertising within three to six months. The organization is currently evaluating various vendors.
Digital Marketing, Advertising, Video
Project
, according to a high-level source in advertising & promotion, is planning to begin initiatives related to native and content advertising within six to nine months.
Advertising, Content Management
Project
Advertising, Automation, Sales, Artificial Intelligence
ProVerum News & Media
ProVerum Announces First Commercial Cases Completed with the ProVee® System for BPH
DUBLIN, Jan. 21, 2026 /PRNewswire/ -- ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced the first commercial cases in the United States have taken place with its ProVee System for...FDA Approves the ProVee System - the First of a New Generation of Prostatic Urethral Stents for Treatment of BPH
DUBLIN, Dec. 9, 2025 /PRNewswire/ -- ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced it has received FDA approval for its ProVee® System for BPH. The ProVee System is a...ProVerum Secures $80 Million Series B Financing to Advance New Treatment for BPH
DUBLIN, Aug. 25, 2025 /PRNewswire/ -- ProVerum Limited, the developer of the ProVee® System for BPH, a minimally invasive solution for treating benign prostatic hyperplasia (BPH), announced today the closing of an $80 million Series B equity financing. The financing was led by MVM...ProVerum Welcomes Tyler Binney to the Board of Directors
DUBLIN, April 25, 2025 /PRNewswire/ -- ProVerum Ltd., the developer of the ProVee® System for BPH, a minimally invasive solution for treating benign prostatic hyperplasia (BPH), announced today the appointment of Tyler Binney to its Board of Directors. Tyler has an outstanding track...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ProVerum
Sign Up For FreeTo access detailed company insights
ProVerum Ltd. is an innovative Dublin based company focused on the development of novel minimally invasive technologies to treat BPH. The company's first product offering, the ProVee® System for BPH is an investigational device, limited by federal law to investigational use and not available for sale within the United States.... Read More
